Effectiveness of Gum Chewing on Polyethylene Glycol Related Intake Adherence, GI Side Effects and Bowel Preparation
1 other identifier
interventional
60
1 country
1
Brief Summary
Problem statement An Experimental Study to assess the effectiveness of Gum Chewing on Polyethylene Glycol (PEG) Related Intake Adherence, GI Side Effects and Bowel Preparation among Patients Undergoing Colonoscopy at ILBS, New Delhi. Objectives of the study The objectives of the study are: Primary objective 1\. To compare the effect of gum chewing in experimental vs. control groups in terms of PEG Related Intake Adherence, GI side effects and Bowel Preparation among Patients Undergoing Colonoscopy. Secondary objective
- 1.To find the relationship of total amount of fluid taken with GI side effects and Bowel Preparation variables in patients undergoing colonoscopy under experimental group.
- 2.To determine the association of PEG Related Intake Adherence, GI side effects and Bowel Preparation among Patients with socio-demographic and clinical variables in patients undergoing colonoscopy under experimental group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2021
CompletedFirst Submitted
Initial submission to the registry
December 30, 2021
CompletedFirst Posted
Study publicly available on registry
April 14, 2022
CompletedMay 13, 2022
January 1, 2022
13 days
December 30, 2021
May 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of patients with complete intake of PEG solution (2 litre) in both groups
Intake Adherence among Patients Undergoing Colonoscopy was assessed by Intake Adherence tool comprises of 4 items which include time spent in ingesting the whole PEG solution in minutes, total amount of PEG solution taken, extra fluid taken other than PEG solution, total amount of fluid taken in milliliters.
up to 5 weeks
Number of patients with change in GI side effects related to PEG solution in both groups
GI side effects among Patients Undergoing Colonoscopy was assessed by Numerical Rating Scale and the Rhodes Index of Nausea, Vomiting, And Retching (INVR).
up to 5 weeks
Improvement in bowel preparation in both groups
Bowel Preparation among Patients Undergoing Colonoscopy was assessed by Boston Bowel Preparation Scale. A four-point scoring system with maximum score of 9 and minimum score of 0 applied to each of the three broad regions of the colon: the right colon (including the cecum and ascending colon), the transverse colon (including the hepatic and splenic flexures), and the left colon (including the descending colon, sigmoid colon, and rectum).
up to 5 weeks
Study Arms (2)
Chewing gums with PEG solution
EXPERIMENTALThe investigator provide the chewing gums with PEG solution to the experimental group.
Standard of Care
ACTIVE COMPARATORCare provided as per the standard existing routine.
Interventions
Patients undergoing colonoscopy under experimental group was advised to take 2L of PEG solution and packets of sugarless sweet mint flavored chewing gums. The patients are advised to Chew one stick of sugarless gum for at least 10 min after taking each glass of PEG solution and discard the chewing gum before taking next glass.
Eligibility Criteria
You may qualify if:
- OPD Patients who -
- Have been planned for elective colonoscopy for therapeutic and/or diagnostic purposes.
- Have been prescribed PEG solution for bowel preparation.
- Are able to chew gum.
- Are willing to participate in the study.
- Can read and write English or Hindi.
You may not qualify if:
- Patients who -
- Are critically ill.
- Are on anti-emetic therapy.
- Have some psychiatric issues making them unable to follow the instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pooja Chaudhary
New Delhi, National Capital Territory of Delhi, 110070, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pooja Ms Chaudhary, Nursing
Institute of Liver and Biliary Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2021
First Posted
April 14, 2022
Study Start
November 1, 2021
Primary Completion
November 14, 2021
Study Completion
December 5, 2021
Last Updated
May 13, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share